The problem
Sepsis is a life-threatening condition that affects more than 1 million patients a year in the United States and even more patients around the globe and is one of the leading causes of death. For patients suspected of sepsis or septic shock, rapid initiation of the correct antibiotic therapy is crucial: over 270,000 people lose their lives each year due to sepsis.
Our Solution
The Eugris
A benchtop diagnostic device that employs a single-use cartridge to identify bacterial infection in the blood
antibiotic sensitivity in one hour.
Latest News
Mar 24, 2022 - Baltimore Homecoming: 2022 Crab Tank Astek Diagnostics
Jan 26, 2022 - Technical.ly: RealLIST Startups: These are Baltimore's top 20 standout tech companies of 2022
Jan 18, 2022 - Technical.ly: Y Combinator alum Astek wants to revolutionize antibiotics
Dec 15, 2021 - NSF: Astek Diagnostics is awarded the SBIR
July 12, 2021 - Yahoo: Astek Diagnostics Accepted into the Y Combinator
About Us
Astek Diagnostics is a medical device company, formed in 2020 to commercialize a novel technology for detecting bacterial infections in blood.
Our mission is to fight antibiotic resistance with innovative technology.
Supporters
Copyright © 2022 Astek Diagnostics - All Rights Reserved.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.